RodrÃguez-Nava, C.; Ortuño-Pineda, C.; Illades-Aguiar, B.; Flores-Alfaro, E.; Leyva-Vázquez, M.A.; Parra-Rojas, I.; del Moral-Hernández, O.; Vences-Velázquez, A.; Cortés-Sarabia, K.; Alarcón-Romero, L.d.C.
Mechanisms of Action and Limitations of Monoclonal Antibodies and Single Chain Fragment Variable (scFv) in the Treatment of Cancer. Biomedicines 2023, 11, 1610.
https://doi.org/10.3390/biomedicines11061610
AMA Style
RodrÃguez-Nava C, Ortuño-Pineda C, Illades-Aguiar B, Flores-Alfaro E, Leyva-Vázquez MA, Parra-Rojas I, del Moral-Hernández O, Vences-Velázquez A, Cortés-Sarabia K, Alarcón-Romero LdC.
Mechanisms of Action and Limitations of Monoclonal Antibodies and Single Chain Fragment Variable (scFv) in the Treatment of Cancer. Biomedicines. 2023; 11(6):1610.
https://doi.org/10.3390/biomedicines11061610
Chicago/Turabian Style
RodrÃguez-Nava, Cynthia, Carlos Ortuño-Pineda, Berenice Illades-Aguiar, Eugenia Flores-Alfaro, Marco Antonio Leyva-Vázquez, Isela Parra-Rojas, Oscar del Moral-Hernández, Amalia Vences-Velázquez, Karen Cortés-Sarabia, and Luz del Carmen Alarcón-Romero.
2023. "Mechanisms of Action and Limitations of Monoclonal Antibodies and Single Chain Fragment Variable (scFv) in the Treatment of Cancer" Biomedicines 11, no. 6: 1610.
https://doi.org/10.3390/biomedicines11061610
APA Style
RodrÃguez-Nava, C., Ortuño-Pineda, C., Illades-Aguiar, B., Flores-Alfaro, E., Leyva-Vázquez, M. A., Parra-Rojas, I., del Moral-Hernández, O., Vences-Velázquez, A., Cortés-Sarabia, K., & Alarcón-Romero, L. d. C.
(2023). Mechanisms of Action and Limitations of Monoclonal Antibodies and Single Chain Fragment Variable (scFv) in the Treatment of Cancer. Biomedicines, 11(6), 1610.
https://doi.org/10.3390/biomedicines11061610
